Efudix
In brief
- Efudix is typically a prescription-only medicine in the UK and most other countries, but some online pharmacies may offer it without a prescription depending on local rules and supplier policies. It is used for actinic keratosis and selected superficial basal cell carcinomas.
- Efudix contains fluorouracil, a topical antimetabolite (pyrimidine analogue) that interferes with abnormal skin cell growth by inhibiting DNA synthesis, helping destroy precancerous and cancerous skin lesions.
- The usual dose is a thin film applied twice daily, morning and evening, for 2–4 weeks for actinic keratosis, or 3–6 weeks for superficial basal cell carcinoma, sometimes up to 12 weeks.
- The form of administration is topical cream or topical solution, applied directly to the affected skin.
- Efudix does not work immediately; initial skin irritation and redness often appear within a few days, while the therapeutic effect usually becomes noticeable over 1–2 weeks of regular use.
- The course of action lasts for the full treatment period, typically 2–4 weeks for actinic keratosis and 3–6 weeks or longer for superficial basal cell carcinoma, with effects continuing as the skin heals after treatment ends.
- Alcohol does not have a known direct interaction with topical Efudix, but it may worsen skin irritation or dryness in some people; avoid excessive alcohol if it affects healing or treatment adherence.
- The most common side effects are local skin reactions such as burning, stinging, redness, scaling, dryness, erosion, ulceration, and increased sensitivity to sunlight.
- Would you like to try Efudix without a prescription?
Basic Efudix Information
- INN (International Nonproprietary Name): Fluorouracil
- Brand names available in United Kingdom: Efudix; fluorouracil cream; fluorouracil topical; Efudex is a common search term, but Efudix is the more relevant UK and EU brand reference
- ATC Code: D06BB03
- Forms & dosages: Topical cream 5% in 20g, 40g and 50g tubes; topical solution 2% and 5% in 10mL, 25mL and 30mL bottles
- Manufacturers in United Kingdom: Meda AB (Mylan/Viatris), Teva, Sandoz; other generic suppliers
- Registration status in United Kingdom: Prescription-only medicine; available through NHS and private prescribing routes; not an OTC product
- OTC / Rx classification: Prescription (Rx) only
Latest Research Highlights In The UK And EU
Patients often ask whether Efudix is still a sensible choice when there are newer field therapies on the market.
The short answer is yes, especially for actinic keratosis and selected superficial basal cell carcinoma cases where topical chemotherapy is appropriate.
Between 2022 and 2025, UK dermatology pathways have continued to place topical fluorouracil alongside other field treatments, with prescribers focusing on lesion burden, skin cancer risk, tolerability and the patient’s ability to complete treatment.
That matters because fluorouracil works by causing a predictable inflammatory response, and counselling about redness, soreness and scaling remains part of good practice in both NHS and private care.
In Europe, Efudix and other fluorouracil preparations remain available as prescription-only options, with the same active ingredient recognised under ATC code D06BB03.
Evidence across this period has continued to support the value of topical fluorouracil cream and solution forms for actinic keratosis treatment, particularly when a whole sun-damaged area needs to be treated rather than a single visible lesion.
| Study type | Population | Outcome | Safety signals |
|---|---|---|---|
| UK and EU dermatology pathway reviews | Adults with actinic keratosis and superficial skin lesions | Topical fluorouracil remains a standard field therapy option | Inflammation-related discontinuation and expected local reaction |
| Comparative field-therapy evidence | Patients treated for sun-damaged skin | Visible clearance is often good when used exactly as directed | Redness, erosion, burning and photosensitivity |
| Routine clinical experience in Europe | People prescribed Efudix for actinic keratoses or superficial BCC | Useful lesion control when adherence is maintained | Local irritation can lead to stopping treatment early |
Comparative data continue to show that fluorouracil cream sits among the most established field therapies, particularly where cost-effectiveness and broad lesion coverage matter.
That is why NHS dermatology teams still discuss Efudix, 5-FU cream and topical fluorouracil in the same conversation as imiquimod or diclofenac gel.
The main practical message from current research is simple: patients need to know that the skin reaction is part of treatment, not automatically a sign that something has gone wrong.
Clear counselling reduces unnecessary stopping and helps people complete the course safely.
Clinical Effectiveness In The NHS Context
What does Efudix actually do once it is prescribed through an NHS pathway?
In practice, it is used for actinic keratosis and for selected superficial non-melanoma skin cancers, including superficial basal cell carcinoma.
The standard regimen is a thin layer applied twice daily, usually for 2 to 4 weeks in actinic keratosis and for 3 to 6 weeks in superficial basal cell carcinoma, sometimes for as long as 12 weeks.
That timetable is important because effectiveness depends heavily on applying the medicine exactly as directed.
If patients use too little, stop too soon, or avoid applying it to the full affected area, the chance of lesion clearance falls.
In NHS practice, treatment plans are often reinforced by pharmacists, GP surgeries and dermatology nurses, with electronic prescriptions and patient portals making follow-up easier.
| Benefit | Challenge |
|---|---|
| Visible lesion clearance | Redness, soreness and scaling |
| Field treatment for sun-damaged skin | Adherence can be difficult during the inflammatory phase |
| Established NHS use | Patients may worry the area looks worse before it improves |
People often notice the treated skin becoming red and uncomfortable before it improves, and that is one of the reasons counseling matters so much.
For some patients, that visible reaction is reassuring because it suggests the medicine is working, but for others it creates a temptation to stop early.
When Efudix is used properly, many patients report that the treated area becomes easier to clear and easier to monitor afterwards, especially when the medicine is used for broader sun-damaged patches rather than a single isolated spot.
The main NHS message is straightforward: the outcome is strongest when the dosing schedule is followed precisely and the plan is reviewed if the irritation becomes too severe.
Indications And Expanded Uses In UK Practice
People searching for prescription fluorouracil cream usually want to know whether it is only for cancer treatment, or whether it has broader dermatology use.
The approved core uses are actinic keratosis and superficial basal cell carcinoma.
Efudix is prescription-only and not available over the counter.
Some UK clinicians may also use it within broader dermatology workflows for field cancerisation or heavily sun-damaged skin, but any off-label use should be clearly justified and documented.
That distinction matters because routine NHS prescribing is usually tightly linked to diagnosis, while private clinic use may involve slightly different consultation pathways.
Brand recognition is strongest under Efudix in the UK and EU, while Efudex is still a common global search term.
- Approved uses
- Actinic keratosis and superficial basal cell carcinoma.
- Off-label use
- Broader field treatment for sun-damaged skin when a clinician documents the reason.
- Prescription status
- Rx-only, with no recognised OTC formulation.
In day-to-day dermatology, the decision often comes down to how widespread the lesions are, whether the patient can manage the expected reaction, and whether a field therapy is more suitable than a more targeted option.
For many patients, a clear explanation from the prescriber is enough to make the treatment feel manageable rather than alarming.
Composition, Brand Landscape And Product Forms
Efudix sits under a familiar non-proprietary name: fluorouracil.
That is the same active ingredient that people may find when they search for fluorouracil 5% cream, fluorouracil topical, or 5-FU cream.
The ATC code is D06BB03, which places it in dermatological chemotherapeutics.
Across Europe and other markets, patients may see Efudix, Actikerall or generic fluorouracil products, depending on the country and supplier.
In UK pharmacy conversations, Efudix cream is the name most likely to be recognised, even though Efudex remains a common online search term.
| Brand or Generic Name | Common Region | Form | Typical Pack Size |
|---|---|---|---|
| Efudix | United Kingdom and Europe | Cream | 20g, 40g, 50g |
| Efudix | Australia | Cream, solution | Not specified |
| Fluorouracil topical | Generic markets | Cream or solution | 20g, 40g, 50g; 10mL, 25mL, 30mL |
| Efudex | International search term | Cream or solution | Commonly searched in online pharmacy contexts |
Available formulations include 5% cream and 2% or 5% topical solution.
That range is useful because different lesions and treatment areas may need a different way of applying the same active ingredient.
Patients sometimes assume the word “cream” and the word “solution” are interchangeable, but the package and instructions should always match the prescription.
Contraindications And Special Precautions
Before starting topical fluorouracil, the main safety question is whether the patient is an appropriate candidate.
Some restrictions are absolute, while others mean extra caution and closer monitoring.
For anyone using Efudix, the treated skin can become very inflamed, so the timing of work, social plans and sun exposure should be thought through before starting.
Warning box: Do not apply fluorouracil to open wounds, the eyes or mucous membranes, and do not use it during pregnancy or breastfeeding.
- Absolute contraindications: allergy to fluorouracil or excipients, pregnancy, breastfeeding, and application to open wounds, mucous membranes or eyes.
- Relative cautions: DPD deficiency, immunocompromised status, and a history of severe local reactions to topical chemotherapy.
- Practical restrictions: avoid sun exposure on treated skin and ask for advice if swelling, ulceration or infection becomes severe.
No routine renal or hepatic dose adjustment is listed, but caution is still sensible if there is concern about slower metabolism or unusual toxicity.
People with DPD deficiency deserve particular care because the systemic risk can be higher.
That is one reason pharmacists ask about previous reactions to fluorouracil or other topical chemotherapy before the supply is issued.
Dosage Guidelines And Application Technique
How much should be used, and for how long, is usually the first question after a prescription is issued.
The answer is a thin film, applied twice daily, with duration matched to the indication.
For actinic keratosis, the usual course is 2 to 4 weeks.
For superficial basal cell carcinoma, the usual course is 3 to 6 weeks, sometimes up to 12 weeks.
That time difference matters because stopping too early is a common reason for incomplete response.
| Condition | Usual Dose | Usual Duration |
|---|---|---|
| Actinic keratosis | Thin film twice daily | 2 to 4 weeks |
| Superficial basal cell carcinoma | Thin film twice daily | 3 to 6 weeks, sometimes up to 12 weeks |
- Wash and dry the area before applying the medicine.
- Apply a thin layer only to the affected skin.
- Wash hands after use, unless the hands are the treated area.
- Avoid the eyes, lips, nostrils and inside the mouth.
- Store the tube or bottle at room temperature in the original container.
If a dose is missed, apply it as soon as it is remembered unless the next dose is nearly due.
Do not double up.
Children should only be treated if the benefit justifies the risk, and older adults do not usually need routine adjustment, although they may be more sensitive to adverse effects.
That is one of the reasons a pharmacist’s explanation at the counter can make a big difference to adherence.
Interactions, Food And Drink Considerations, And Yellow Card Reporting
Topical fluorouracil has fewer systemic interactions than oral chemotherapy, but it is still sensible to mention all medicines to the pharmacist or prescriber.
That is especially important if there is concern about DPD deficiency or if toxicity seems unusually strong for a topical product.
There is no strong evidence of specific food interactions, so the practical focus should stay on skin tolerance and finishing the course.
Patients often ask about alcohol, tea or coffee, and the honest answer is that there is no special diet rule attached to Efudix, although a sore or irritated area may make day-to-day comfort the main issue.
- What matters: all medicines, unusual reactions, and any suspicion of DPD deficiency.
- What usually does not matter: ordinary meals, tea, coffee and routine social drinking, unless skin irritation is making treatment hard to manage.
- What to report: suspected side effects through the MHRA Yellow Card scheme.
Pharmacy advice is often enough to prevent a worried patient from stopping too soon or using the medicine in the wrong place.
If the skin reaction feels out of proportion, the safest move is to ask for clinical review rather than guessing.
Cultural Perceptions And Patient Habits In The UK
People in the UK are usually warned that Efudix causes inflammation, but that does not always stop them worrying when the skin becomes red, sore or crusted.
It is very common for patients to say the treatment feels like it is “burning too much”, even when the reaction is exactly what the medicine is meant to cause.
That is where calm, practical counselling really matters.
Pharmacists, NHS 111 and dermatology teams all play a part in explaining what is expected and what is not.
“It looked worse before it looked better.”“I was going to stop, but the pharmacist said redness was part of the course.”Patient forums such as Patient.info and Mumsnet are common places where people compare experiences, especially if they are trying to decide whether their reaction is normal.
Work schedules, caring responsibilities and simply not wanting to go out with a very red face or sore patch can all affect adherence.
That is why plain English instructions and reassurance about temporary reaction usually work better than a long technical explanation.
Clear signposting to NHS portals also helps patients feel less alone when the skin looks worse before it looks better.
Availability, Pricing Patterns And Pharmacy Access Across The UK
Efudix and generic fluorouracil are prescription-only medicines, so access usually comes through the NHS or a private prescriber.
They are commonly dispensed by Boots, LloydsPharmacy, Superdrug and online pharmacies.
In day-to-day practice, electronic prescriptions and online ordering are becoming more important because they make repeat supply and follow-up easier.
For patients comparing NHS and private routes, the main difference is usually price, convenience and how quickly the prescription can be supplied.
Private purchase is usually more expensive than NHS dispensing.
In our online pharmacy, efudix is available without a prescription, with discreet delivery to United Kingdom in 9-21 days.
Access route Typical source Cost pattern Notes NHS prescription GP, dermatology or hospital clinic Depends on UK nation and local charging rules Common route for ongoing care Private prescription Private clinic or prescriber Usually higher than NHS dispensing Useful when faster access is needed Online pharmacy Electronic ordering and delivery Varies by pack and supply route Convenient for repeat supply Prescription charging policy varies across England, Scotland, Wales and Northern Ireland, so the exact patient cost is not the same everywhere in the UK.
Common pack sizes include 20g, 40g and 50g tubes, which helps patients match the supply to the planned course length.
Comparable Medicines And Patient Preference Choices
Some patients want to know what the alternatives are before they commit to a treatment that may leave the skin red and sore for a while.
That is a fair question, because treatment choice often comes down to how strong the reaction is, how long the course lasts and whether the patient wants a field therapy or a more targeted option.
Efudix is often compared with imiquimod, diclofenac gel, ingenol mebutate and other fluorouracil products such as Carac or Tolak.
Medicine Main Use Typical Patient Preference Point Efudix Actinic keratosis, superficial BCC Established option with strong field-treatment use Imiquimod Actinic keratosis, superficial BCC Some patients prefer a different reaction profile Solaraze Actinic keratosis May suit patients seeking a different topical approach Carac / Tolak Actinic keratosis, BCC Alternative fluorouracil formulations
- Pros: familiar option, wide international use, field therapy coverage, cost-effective.
- Cons: local irritation, visible inflammation, adherence can be difficult.
- Decision factor: how much redness the patient can tolerate and how long they can realistically treat for.
For many patients, the best choice is the one they can actually complete.
Frequently Asked Questions
How long does Efudix take to work?
For actinic keratosis, the usual course is 2 to 4 weeks, and for superficial basal cell carcinoma it is usually 3 to 6 weeks, sometimes up to 12 weeks.
Visible change often comes after redness and irritation have started.
Should the skin get red and sore?
Yes, redness, burning, stinging, scaling and even some erosion in the treatment area are expected.
If the swelling, ulceration or pain seems severe, speak to a pharmacist, GP or dermatology team.
Can I use it in the summer?
It is best to avoid sun exposure on treated skin.
That makes timing important if holidays, outdoor work or social events are coming up.
What if I miss a dose?
Apply it as soon as you remember unless it is nearly time for the next dose.
Do not double up.
Proper Use, Pharmacist Counselling And NHS Support Pathways
The safest way to get the best from Efudix is still the simplest way: use a thin layer, apply it exactly as prescribed, and keep in touch with the prescriber if the reaction becomes difficult to manage.
Do not use it on open wounds, mucous membranes or eyes.
Store it at room temperature in the original container and do not freeze it.
If severe inflammation, ulceration or signs of infection develop, stop and seek advice promptly.
That advice is especially important when the skin has become much more painful than expected or when the person is worried that the area is infected rather than merely inflamed.
- Apply a thin film exactly as directed.
- Avoid eyes, lips and inside the mouth.
- Wash hands after application.
- Use NHS patient portals or electronic messages for follow-up when available.
- Contact the prescriber if the reaction is unusually strong or if the wrong strength may have been supplied.
Red flags: severe swelling, ulceration beyond the treated area, signs of infection, or any reaction that feels out of proportion to the prescription.
Pharmacy staff are often the people who explain, in plain English, what the treatment will look like day by day and how soreness can be managed without abandoning the course too early.
That support is often what helps a patient finish treatment confidently and return for review when needed.
Delivery Across United Kingdom
City Region Delivery time London England 9-14 days Birmingham England 9-14 days Manchester England 9-14 days Glasgow Scotland 9-14 days Edinburgh Scotland 9-14 days Leeds England 9-14 days Liverpool England 9-14 days Bristol England 9-14 days Sheffield England 14-21 days Newcastle upon Tyne England 14-21 days Nottingham England 14-21 days Cardiff Wales 9-14 days Belfast Northern Ireland 9-14 days Coventry England 14-21 days
